uniQure and Chiesi to commercialize Glybera, co-develop gene therapy for hemophilia B
As part of the agreement, uniQure has achieved $21.8m (€17m) in financing agreement as well as $18m (€14m) in equity financing from Chiesi. It has also converted the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.